Genetic counselors: Translating genomic science into clinical practice

Journal of Clinical Investigation

Volumn 112, Issue 9, 2003, Pages 1274-1279

  Bennett, Robin L ^a   Hampel, Heather L ^b   Mandell, Jessica B ^a   Marks, Joan H ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c SARAH LAWRENCE COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT DISEASE; ADULT ONSET DISEASE; BREAST CANCER; CANCER; CLINICAL PRACTICE; FAMILIAL CANCER; GENE PATENT; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC COUNSELOR; GENETIC RISK; GENOMICS; HEALTH; HEALTH PRACTITIONER; HEREDITARY BREAST OVARIAN CANCER SYNDROME; HUMAN; JUVENILE; ONSET AGE; OVARY CANCER; PATENT; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT;

EID: 0346095411     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI20113     Document Type: Review

References (55)

1. Marks, J.H., and Richter, M.L. 1976. The genetic associate: a new health professional. Am. J. Public Health. 66:388-390.
2. Walker, A.P. 1998. The practice of genetic counseling. In A guide to genetic counseling. D.L. Baker, J.L. Schuette, and W.R. Uhlmann, editors. Wiley-Liss Inc. New York, New York, USA. 1-26.
3. Ad Hoc Committee on Generic Counseling. 1975. Report to the American Society of Human Genetics. Am. J. Hum. Genet. 27:240-242.
4. Biesecker, B., and Peter, K. 2002. Genetic counseling: ready for a new definition? J. Genet. Couns. 11:536-537. (Abstr.)
5. Weil, J. 2003. Psychosocial genetic counseling in the post-nondirective era: a point of view. J. Genet. Couns. 12:199-211.
6. Biesecker, B.B. 2003. Back to the future of genetic counseling: commentary on "psychosocial genetic counseling in the post-nondirective era." J. Genet. Couns. 12:213-217.
7. Burke, W., Pinsky, L.E., and Press, N.A. 2001. Categorizing genetic tests to identify their ethical, legal and social implications. Am. J. Med. Genet. 106:233-240.
8. Elwyn, G., Gray, J., and Clarke, A. 2000. Shared decision making and non-directiveness in genetic counseling. J. Med. Genet. 37:135-138.
9. Jansen, L.A. 2001. Role of the nurse in clinical genetics. In Genetics in the clinic: clinical, ethical and social implications for primary care. M.B. Mahowald, A.S. Scheurle, V.A. McKusick, and T.J. Aspinwall, editors. Mosby Publishing. St. Louis, Missouri, USA, 133-141.
10. McConkie-Rosell, A., and Sullivan, J.A. 1999. Genetic counseling: stress, coping, and the empowerment perspective. J. Genet. Couns. 8:345-357.
11. Shiloh, S., Berkenstadt, M., Meiran, N., Bat-Miriam-Katznelson, M., and Goldman, B. 1997. Mediating effects of perceived personal control in coping with a health threat: the case of genetic counseling. J. Appl. Soc. Psychol. 27:1146-1174.
12. Bennett, R.L., Steinhaus, K.A., Uhrich, S.B., and O'Sullivan, C. 1993. The need for developing standardized pedigree nomenclature. J. Genet. Couns. 2:261-273.
13. Bennett, R.L., et al. 1995. Recommendations for standardized human pedigree nomenclature. Am. J. Hum. Genet. 56:745-752.
14. Bennett, R.L. 1999. The practical guide to the genetic family history. Wiley-Liss Inc. New York, New York, USA. 251 pp.
15. Schneider, K. 2002. Counseling about cancer: strategies for genetic counseling. Wiley-Liss Inc. New York, New York, USA. 333 pp.
16. 2000. Psyche and helix: psychological aspects of genetic counseling. R.G. Resta, editor. Wiley-Liss Inc. New York, New York, USA. 180 pp.
17. Weil, J. 2000. Psychosocial genetic counseling. Oxford University Press. New York, New York, USA. 291 pp.
18. Jonsen, A.R., Durfy, S.J., Burke, W., and Motulsky, A.G. 1996. The advent of the "unpatients." Nat. Med. 2:622-624.
19. American Society of Human Genetics/American College of Medical Genetics Reports. 1995. Points to consider: ethical, legal and psychological implications of genetic testing in children and adolescents. Am. J. Hum. Genet. 57:1233-1241.
20. National Society of Genetic Counselors. 1994. Position statement on prenatal and childhood testing for adult-onset disorders. Perspectives in Genetic Counseling. 17:5.
21. American Academy of Pediatrics, Committee on Genetics. 2000. Molecular genetic strategies in pediatric practice: a subject review. Pediatrics. 106:1494-1497.
22. Peters, J.A., and Biesecker, B.B. 1997. Genetic counseling and hereditary cancer. Cancer Supplement. 80:576-586.
23. Douglas, F., O'Dair, L., Robinson, M., Evans, D.G., and Lynch, S.A. 1999. The accuracy of diagnoses as reported in families with cancer: a retrospective study. J. Med. Genet. 36:309-312.
24. Schmidt, S., Becher, H., and Chang-Claude, J. 1998. Breast cancer risk assessment: use of complete pedigree information and the effect of misspecified ages at diagnosis of affected relatives. Hum. Genet. 102:348-356.
25. Bergmann, M., et al. 1998. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am. J. Epidemiol. 147:556-562.
26. Parent, M., Ghadirian, P., Lacroix, A., and Perret, C. 1997. The reliability of recollections of family history: implications for the medical provider. J. Cancer Educ. 12:114-120.
27. Aitken, J., Bain, C., Ward, M., Siskind, V., and MacLennan, R. 1995. How accurate is self-reported family history of colorectal cancer? Am. J. Epidemiol. 141:863-871.
28. Love, R., Evans, A., and Josten, D. 1985. The accuracy of patient reports of a family history of cancer. J. Chronic Dis. 38:289-293.
29. Novakovic, B., Goldstein, A.M., and Tucker, M.A. 1996. Validation of family history of cancer in deceased family members. J. Natl. Cancer Inst. 88:1492-1493.
30. Lynch, H.T., Snyder, C.L., Lynch, J.F., Riley, B.D., and Rubinstein, W.S. 2003. Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist. J. Clin. Oncol. 21:740-753.
31. Narod, S.A. 2002. Modifiers of risk of hereditary breast and ovarian cancer. Nat. Rev. Cancer. 2:113-123.
32. Robson, M.E. 2002. Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer. Cancer Control. 9:457-465.
33. Knudson, A.G. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. U. S. A. 68:820-823.
34. Antoniou, A., et al. 2003. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72:1117-1130.
35. Struewing, J.P., et al. 1997. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med. 336:1401-1408.
36. Wooster, R., et al. 1994. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 265:2088-2090.
37. 1999. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J. Natl. Cancer Inst. 91:1310-1316.
38. Burke, W., et al. 1997. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 277:997-1003.
39. Daly, M. 2002. National Comprehensive Cancer Network Practice Guidelines. Genetic/Familial high-risk assessment: breast and ovarian. Version 1.2003. http://www.nccn.org/physician_gls/f_guidelines.html.
40. Rebbeck, T. R., et al. 2002. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 346:1616-1622.
41. Hartmann, L., et al. 2001. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J. Natl Cancer Inst. 93:1633-1637.
42. Benowicz, S. 2003. European groups oppose Myriad's latest patent on BRCA1. J. Natl. Cancer Inst. 95:8-9.
43. Matthijs, G., et al. 2002. Patents and monopolies on diagnostic tests: Europe's opposition against the BRCA1 patents. Am. J. Hum. Genet. 71:182, (Abstr. 93).
44. 2003. Gene patents and the public good. Nature. 423:207.
45. Pearson, H. 2003. Genetic test adverts under scrutiny. Nature Science Update. http://www.nature.com/nsu/030317/030317-3.html.
46. Moreno, J. 2002. Selling genetic tests: shades of gray in your DNA. ABCNEWS.com.http://abc-news.go.com/sections/living/DailyNews/ ONCALL_DTC_brca_rests020923.html.
47. Starink, T.M., et al. 1986. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin. Genet. 29:222-233.
48. Brownstein, M.H., Wolf, M., and Bilowski, J.B. 1978. Cowden's disease: a cutaneous marker of breast cancer. Cancer. 41:2393-2398.
49. Li, F.P., et al. 1988. A cancer family syndrome in twenty-four kindreds. Cancer Res. 51:6094-6097.
50. Boardman, L., et al. 1998. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann. Intern. Med. 128:896-899.
51. Giardiello, F.M., et al. 1987. Increased risk of cancer in the Peutz-Jeghers syndrome. N. Engl. J. Med. 316:1511-1514.
52. Olsen, J.H., et al. 2001. Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J. Natl. Cancer Inst. 93:84-85.
53. Swift, M., Morrell, D., Massey, R.B., and Chase, C.L. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N. Engl. J. Med. 325:1831-1836.
54. Meijers-Heijboer, H., et al. 2002. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet. 31:55-59.
55. Meijers-Heijboer, H., et al. 2003. The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am. J. Hum. Genet. 72:1308-1314.